Related Articles
Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer
Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer
Neuroendocrine differentiation is predictive of poor survival in patients with stageĀ II colorectal cancer
LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A MULTIMODAL THERAPY INCLUDING ALTERNATING NEOADJUVANT CHEMOTHERAPY, SURGERY AND RADIOTHERAPY
Clinical analysis of bevacizumab targeting therapy in treating early colorectal carcinoma after operation